U.S. flag

An official website of the United States government

NM_001323289.2(CDKL5):c.1852_1853insT (p.Asp618fs) AND Developmental and epileptic encephalopathy, 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 14, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001089704.1

Allele description [Variation Report for NM_001323289.2(CDKL5):c.1852_1853insT (p.Asp618fs)]

NM_001323289.2(CDKL5):c.1852_1853insT (p.Asp618fs)

Gene:
CDKL5:cyclin dependent kinase like 5 [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
Xp22.13
Genomic location:
Preferred name:
NM_001323289.2(CDKL5):c.1852_1853insT (p.Asp618fs)
HGVS:
  • NC_000023.11:g.18604776_18604777insT
  • NG_008475.1:g.184172_184173insT
  • NM_001037343.2:c.1852_1853insT
  • NM_001323289.2:c.1852_1853insTMANE SELECT
  • NM_003159.3:c.1852_1853insT
  • NP_001032420.1:p.Asp618fs
  • NP_001310218.1:p.Asp618fs
  • NP_003150.1:p.Asp618fs
  • NP_003150.1:p.Asp618fs
  • NC_000023.10:g.18622896_18622897insT
  • NM_003159.2:c.1852_1853insT
  • p.Asp618Valfs*21
Protein change:
D618fs
Links:
dbSNP: rs1926303951
NCBI 1000 Genomes Browser:
rs1926303951
Molecular consequence:
  • NM_001037343.2:c.1852_1853insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001323289.2:c.1852_1853insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_003159.3:c.1852_1853insT - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 2 (DEE2)
Synonyms:
INFANTILE SPASM SYNDROME, X-LINKED 2; Early infantile epileptic encephalopathy 2
Identifiers:
MONDO: MONDO:0010396; MedGen: C4750718; Orphanet: 1934; Orphanet: 3451; OMIM: 300672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001245187Laboratory of Inherited Metabolic Diseases, Research centre for medical genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 14, 2020)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory of Inherited Metabolic Diseases, Research centre for medical genetics, SCV001245187.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023